98%
921
2 minutes
20
The aim of the present study was to determine the molecular mechanism by which the hepatocyte growth factor (HGF) receptor (cMet) regulates lymphatic metastasis in hepatocellular carcinoma. Mouse hepatoma ascites cell lines with different lymph node metastatic potentials, Hca‑F (high metastatic potential) and Hca‑P (low metastatic potential), were cultured in vitro. Cells were treated with HGF, fibronectin (FN) and laminin (LN), and the phosphorylated tyrosine residues of cMet and the activities of intracellular phospholipase Cγ/diacylglycerol/protein kinase C (PLCγ/DAG/PKC) and phosphoinositol‑3‑kinase/protein kinase B (PI3K/AKT) signaling pathways were analyzed comparatively in the two cell lines using western blot analysis and migration assays. Following HGF treatment, the phosphorylation of cMet at Tyr 1313 and 1365 in Hca‑F cells was higher, while the phosphorylation of cMet at Tyr 1349 was lower than that in Hca‑P. The activity of PLCγ/DAG/PKC was increased in Hca‑F cells compared with Hca‑P cells, whereas the activity of PI3K/AKT was reduced. After FN treatment, the phosphorylation of cMet at Tyr 1313 and the activity of the PLCγ/DAG/PKC signaling pathway was increased in Hca‑F cells compared with Hca‑P cells. Following LN treatment, the phosphorylation of cMet at Tyr 1365 and the activity of PLCγ/DAG/PKC was higher in Hca‑F cells than in Hca‑P cells. Results of the current study indicate that a number of ligands stimulate the phosphorylation of cMet at various tyrosine residues, activating different signaling transduction pathways. In addition, the same ligand was observed to phosphorylate different tyrosine residues on cMet in the two cell lines, as well as activate different intracellular signaling transduction pathways. After cMet is activated, various tyrosine residues are phosphorylated, leading to the activation of the PI3K/AKT and PLCγ/DAG/PKC signaling pathways to different extents in the two cells lines. These results may be important in determining the lymph node metastatic potentials of the two cell lines.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3892/mmr.2013.1527 | DOI Listing |
Eur J Pharmacol
September 2025
Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, P. R. China; Henan Key Laboratory of Precision Clinical Pharmacy, Zhengzhou, P. R. China. Electronic address:
Drug-induced liver injury is a major cause of acute liver failure. Crizotinib is a first-line treatment for patients with cellular-mesenchymal epithelial transition factor (c-MET), anaplastic lymphoma kinase (ALK), and ROS proto-oncogene 1 (ROS1)-positive non-small cell lung cancer. Although some patients treated with crizotinib experience hepatic adverse effects, the underlying mechanisms remain unclear.
View Article and Find Full Text PDFCancer Lett
August 2025
Division of Nephrology, Boston Children's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address:
The mechanisms underlying therapeutic resistance to c-Met/receptor tyrosine kinase (RTK) inhibitors in renal cancer remain unexplored. In renal cell carcinoma (RCC) cells, both AXL and c-Met are highly upregulated. Notably, we found that prolonged treatment with the c-Met/RTK inhibitor, cabozantinib (Cabo), a standard treatment for advanced-stage RCC, markedly increased total c-Met levels and promoted renal cancer cell proliferation.
View Article and Find Full Text PDFInt J Mol Sci
July 2025
Institute of Experimental Cardiology Named after Academician V.N. Smirnov, Federal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov, Ministry of Health of the Russian Federation, 121552 Moscow, Russia.
Epicardial mesothelial cells (EMCs), which form the epicardium, play a crucial role in cardiac homeostasis and repair. Upon damage, EMCs reactivate embryonic development programs, contributing to wound healing, progenitor cell amplification, and regulation of lymphangiogenesis, angiogenesis, and fibrosis. However, the mechanisms governing EMC activation and subsequent regulation remain poorly understood.
View Article and Find Full Text PDFBiochem Biophys Res Commun
September 2025
Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, 47-1 Nodayama, Medeshima-Shiote, Natori, Miyagi, 981-1293, Japan; Division of Carcinogenesis and Senescence Biology, Tohoku University Graduate School of Medicine, 47-1 Nodayama, Medeshima-Shiote, Natori, Miyagi, 981-1293, Japan.
Renal cell carcinoma (RCC), the most common types of kidney cancer, still requires novel therapeutic targets to improve patients' outcome. In this study, we focus on Failed Axon Connections Homolog (FAXC) gene, a newly identified and potentially important cancer target, and investigated its detailed role in RCC. In RCC cells, FAXC knockdown resulted in increased cell proliferation, and elevated c-MET expression and phosphorylation.
View Article and Find Full Text PDFAnticancer Res
July 2025
Department of Orthopedics, Uonuma Kikan Hospital, Niigata, Japan.
Background/aim: Osteosarcoma (OS) treatment is challenging owing to chemoresistance and toxicity. Aberrant c-Met signaling drives OS progression, however, monotherapy with c-Met inhibitors is limited by resistance. Methotrexate (MTX), a cornerstone of OS chemotherapeutic, inhibits folate metabolism while sharing pathway crosstalk with c-Met signaling.
View Article and Find Full Text PDF